Journey Medical Corporation
DERM
$7.69
$0.283.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.38% | 1.04% | 0.84% | -17.28% | -4.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.52% | 1.04% | 0.84% | -10.73% | -57.64% |
| Cost of Revenue | 28.72% | -13.76% | -20.19% | -0.49% | -30.46% |
| Gross Profit | 16.91% | 10.32% | 18.80% | -12.50% | -63.86% |
| SG&A Expenses | 5.77% | 15.05% | 25.52% | 2.23% | 31.96% |
| Depreciation & Amortization | 30.71% | 30.71% | 30.84% | -9.11% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.34% | 0.58% | -28.79% | -34.42% | 1.32% |
| Operating Income | 47.17% | 1.74% | 67.06% | 206.18% | -116.78% |
| Income Before Tax | 3.14% | -11.16% | 60.99% | 178.43% | -114.16% |
| Income Tax Expenses | -- | -- | -- | -51.59% | -- |
| Earnings from Continuing Operations | 3.14% | -12.94% | 60.99% | 170.98% | -114.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.14% | -12.94% | 60.99% | 170.98% | -114.24% |
| EBIT | 47.17% | 1.74% | 67.06% | 206.18% | -116.78% |
| EBITDA | 77.64% | 14.20% | 75.65% | 349.42% | -111.52% |
| EPS Basic | 20.27% | 3.03% | 65.92% | 162.30% | -112.77% |
| Normalized Basic EPS | 45.79% | 4.57% | 65.91% | 168.84% | -118.67% |
| EPS Diluted | 20.27% | 3.03% | 65.92% | 156.68% | -114.55% |
| Normalized Diluted EPS | 45.79% | 4.57% | 65.91% | 168.84% | -121.33% |
| Average Basic Shares Outstanding | 21.53% | 16.49% | 14.44% | 14.00% | 11.52% |
| Average Diluted Shares Outstanding | 21.53% | 16.49% | 14.44% | 14.00% | -2.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |